To test for an association between CCL5 expression in ICs and chemotherapy response, patients with positive or negative CCL5 expression in ICs were separately considered in the following subgroups: tumor stage, nodal stage, and molecular subtype. This evidence concerns the gene CCL5 and neoplasm.